69 related articles for article (PubMed ID: 2476630)
21. Synthesis and cardiodepressant activity of dialkyl 1,4-dihydro-2,6-dimethyl-4-(pentatomic-heteroaryl)-3,5-pyridine-dicarbo xylates. 2.
Baraldi PG; Garuti L; Leoni A; Cacciari B; Budriesi R; Chiarini A
Drug Des Discov; 1993; 10(4):319-29. PubMed ID: 8148471
[TBL] [Abstract][Full Text] [Related]
22. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
[TBL] [Abstract][Full Text] [Related]
23. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
[TBL] [Abstract][Full Text] [Related]
24. 1,4-Dihydropyridine activators in the tiamdipine series.
Galletti F; Luchowski E; Triggle DJ
Eur J Pharmacol; 1990 Aug; 185(2-3):157-61. PubMed ID: 2147653
[TBL] [Abstract][Full Text] [Related]
25. Vasorelaxant and negative inotropic effects of gallopamil and LU49700, a metabolite of gallopamil, on isolated rat aorta and guinea-pig ventricular myocardium.
Noguchi K; Takahashi K; Kaneko K; Higuchi S
Arzneimittelforschung; 1998 Jan; 48(1):22-5. PubMed ID: 9522026
[TBL] [Abstract][Full Text] [Related]
26. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
Thomas G; Gross R; Schramm M
J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
[TBL] [Abstract][Full Text] [Related]
27. Cardiovascular characterization of pyrrolo[2,1-d][1,5]benzothiazepine derivatives binding selectively to the peripheral-type benzodiazepine receptor (PBR): from dual PBR affinity and calcium antagonist activity to novel and selective calcium entry blockers.
Campiani G; Fiorini I; De Filippis MP; Ciani SM; Garofalo A; Nacci V; Giorgi G; Sega A; Botta M; Chiarini A; Budriesi R; Bruni G; Romeo MR; Manzoni C; Mennini T
J Med Chem; 1996 Jul; 39(15):2922-38. PubMed ID: 8709127
[TBL] [Abstract][Full Text] [Related]
28. [Vasodilator effects of LF 2.0254, a new 1,4-dihydropyridine. Comparison with nifedipine].
Pruneau D; Roy F; Brown NL
Therapie; 1989; 44(3):203-8. PubMed ID: 2781506
[TBL] [Abstract][Full Text] [Related]
29. Negative inotropic and calcium antagonistic activity of alkyl and arylalkyl phosphonates.
Bellucci C; Gualtieri F; Scapecchi S; Teodori E; Budriesi R; Chiarini A
Farmaco; 1989 Dec; 44(12):1167-91. PubMed ID: 2634406
[TBL] [Abstract][Full Text] [Related]
30. Hemodynamic effects of a calcium channel promoter, BAY y 5959, are preserved after chronic administration in ischemic heart failure in conscious dogs.
Yi GH; Burkhoff D; Zhang H; Zhu SM; Zwas D; Wang J
J Pharmacol Exp Ther; 1998 Aug; 286(2):760-6. PubMed ID: 9694931
[TBL] [Abstract][Full Text] [Related]
31. Cardiovascular effects of CPU-23, a novel L-type calcium channel blocker with a unique molecular structure.
Dong H; Earle ML; Jiang Y; Loutzenhiser KA; Triggle CR
Br J Pharmacol; 1997 Dec; 122(7):1271-8. PubMed ID: 9421272
[TBL] [Abstract][Full Text] [Related]
32. 4-heterotricyclic substituted 1,4-dihydropyridines with a potent selective bradycardic effect.
Rampa A; Chiarini A; Bisi A; Budriesi R; Valenti P
Arzneimittelforschung; 1991 Jul; 41(7):705-9. PubMed ID: 1772458
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular effects of benidipine and amlodipine in isolated tissues and anesthetized dogs.
Moriyama T; Karasawa A
Biol Pharm Bull; 1994 Nov; 17(11):1468-71. PubMed ID: 7703965
[TBL] [Abstract][Full Text] [Related]
34. Cardiovascular selectivity of 1,4-dihydropyridine derivatives, efonidipine (NZ-105), nicardipine and structure related compounds in isolated guinea-pig tissues.
Masuda Y; Miyajima M; Shudo C; Tanaka S; Shigenobu K; Kasuya Y
Gen Pharmacol; 1995 Mar; 26(2):339-45. PubMed ID: 7590084
[TBL] [Abstract][Full Text] [Related]
35. Interaction between propranolol and calcium channel blockers in cardiac and vascular smooth muscle.
Weishaar RE; Quade MM; Pugsley TA; Shih YH; Taylor DG
J Mol Cell Cardiol; 1988 Oct; 20(10):897-903. PubMed ID: 3216400
[TBL] [Abstract][Full Text] [Related]
36. Effect of 4-aryl-2-methyl-5-nitro-1,4-dihydropyridine-3-carboxylates on the guinea pig papillary muscle and isolated human vena saphena magna that is used for coronary artery bypass grafting.
Garaliene V; Barsys V; Mačys A; Vigante B; Krauze A
Eur J Med Chem; 2011 Sep; 46(9):4441-7. PubMed ID: 21802798
[TBL] [Abstract][Full Text] [Related]
37. Negative inotropic and chronotropic activity of calcium channel ligands possessing a xanthone 1,4-dihydropyridine backbone.
Chiarini A; Rampa A; Bisi A; Budriesi R; Valenti P
Arzneimittelforschung; 1992 Jun; 42(6):797-801. PubMed ID: 1329778
[TBL] [Abstract][Full Text] [Related]
38. Antiarrhythmic agent amiodarone possesses calcium channel blocker properties.
Lubic SP; Nguyen KP; Dave B; Giacomini JC
J Cardiovasc Pharmacol; 1994 Nov; 24(5):707-14. PubMed ID: 7532747
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, structure, and pharmacological evaluation of the stereoisomers of furnidipine.
Alajarin R; Vaquero JJ; Alvarez-Builla J; Pastor M; Sunkel C; Fau de Casa-Juana M; Priego J; Statkow PR; Sanz-Aparicio J; Fonseca I
J Med Chem; 1995 Jul; 38(15):2830-41. PubMed ID: 7636844
[TBL] [Abstract][Full Text] [Related]
40. Fluorenone and benzophenone 1,4-dihydropyridine derivatives with cardiodepressant activity.
Rampa A; Budriesi R; Bisi A; Chiarini A; Valenti P
Arzneimittelforschung; 1992 Nov; 42(11):1284-7. PubMed ID: 1492840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
